MENU
+Compare
UNCY
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$0.62
Change
+$0.01 (+1.64%)
Capitalization
64.03M

UNCY Unicycive Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for UNCY with price predictions
Feb 21, 2025

UNCY's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for UNCY turned positive on February 14, 2025. Looking at past instances where UNCY's MACD turned positive, the stock continued to rise in of 33 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where UNCY's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 21, 2025. You may want to consider a long position or call options on UNCY as a result. In of 67 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for UNCY moved above the 200-day moving average on January 15, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UNCY advanced for three days, in of 153 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 35 cases where UNCY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

UNCY moved below its 50-day moving average on January 16, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for UNCY crossed bearishly below the 50-day moving average on January 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for UNCY entered a downward trend on February 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.299) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). UNCY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (39.216) is also within normal values, averaging (251.221).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UNCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

UNCY is expected to report earnings to rise 82.80% to -9 cents per share on March 27

Unicycive Therapeutics UNCY Stock Earnings Reports
Q4'24
Est.
$-0.09
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.09
Q1'24
Missed
by $0.82
Q4'23
Missed
by $0.04
The last earnings report on November 13 showed earnings per share of -5 cents, beating the estimate of -15 cents. With 1.38M shares outstanding, the current market capitalization sits at 64.03M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4300 El Camino Real
Phone
+1 650 351-4495
Employees
14
Web
https://www.unicycive.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALDX6.69-0.03
-0.45%
Aldeyra Therapeutics
BEP23.44-0.14
-0.59%
Brookfield Renewable Partners LP
ZEPP2.97-0.02
-0.67%
Zepp Health Corporation
NBTB46.87-0.47
-0.99%
NBT Bancorp
SHOP115.56-7.91
-6.41%
Shopify

UNCY and Stocks

Correlation & Price change

A.I.dvisor tells us that UNCY and BBIO have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UNCY and BBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
+1.15%
BBIO - UNCY
32%
Poorly correlated
+0.12%
SCPX - UNCY
28%
Poorly correlated
+5.91%
SYRS - UNCY
26%
Poorly correlated
-0.85%
XNCR - UNCY
26%
Poorly correlated
-0.32%
ARWR - UNCY
25%
Poorly correlated
-5.06%
More